glp-1 agonists vs bariatric surgery weight loss comparison Outperforms GLP-1s in In this cohort study of

[DOI] [PubMed] [Google Scholar] 4.Banting FG Early Work on Insulin

13,14,15 By integrating the latest clinical trial data, we explore the efficacy of GLP-1RAs in treating diseases of the nervous, cardiovascular, endocrine, and digestive systems

doi: 10.1210/endocr/bqaf028

The glucagon-like peptide 1 analogue Exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice

Methods Protocol and registration The present systematic review and meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to ensure methodological rigor and transparency

An athlete needing dialysis treatment requires a Therapeutic Use Exemption